
DEA Extends Telehealth Prescribing Rules Through 2026
Table of Contents Article Summary and Context Dr Telx’s Perspective on the Extension The Real-World Impact on Patients Balancing Access with Safety A Modern Approach to Telewellness Conclusion Article Summary and Context The Drug Enforcement Administration recently published its fourth temporary extension of telemedicine prescribing flexibilities for controlled substances, extending pandemic-era policies through December 2026.








